Clinical trial
A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on…
NCT00365001 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00365001 |
|---|---|
| Title | A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis. |
| Official title | A Randomized, Open-label Study to Assess the Pharmacokinetics of Simvastatin and Methotrexate in Combination With Tocilizumab in Patients With Rheumatoid Arthritis. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | tocilizumab [RoActemra/Actemra], Methotrexate, Simvastatin |
| Enrollment | 23 |
| Completion | Apr 1, 2008 |
| First posted | Aug 16, 2006 |
| Last update posted | Jun 11, 2010 |
| Countries | New Zealand, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: